Physician profile
George E Okafor
NPI 1710909817
$2,001.23
in general payments reported to CMS, 2019-2025
17 companies · $426 in 2025
The $426 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $121 · 2021: $212 · 2022: $231 · 2023: $173 · 2024: $613 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,211.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $297.63 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Abbott Laboratories | $272.63 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Amgen INC. | $262.82 | 2023-2025 | Repatha, Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $254.66 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $199.36 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $170.18 | 2022-2025 | Farxiga, Breztri |
| Novo Nordisk INC | $86.68 | 2019-2024 | Rybelsus, Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $85.77 | 2019 | |
| Glaxosmithkline, LLC. | $75.65 | 2024-2025 | Trelegy Ellipta, Shingrix |
| Mannkind Corporation | $59.40 | 2022 | |
| Merck Sharp & Dohme LLC | $56.77 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Exact Sciences Corporation | $40.92 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $39.33 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $35.82 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.90 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $20.93 | 2024 | Dexcom G6 Transmitter |
| E.R. Squibb & Sons, L.L.C. | $15.78 | 2023 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Okafor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.